Cargando…
Fatty Acid Incubation of Myotubes From Humans With Type 2 Diabetes Leads to Enhanced Release of β-Oxidation Products Because of Impaired Fatty Acid Oxidation: Effects of Tetradecylthioacetic Acid and Eicosapentaenoic Acid
OBJECTIVE—Increased availability of fatty acids is important for accumulation of intracellular lipids and development of insulin resistance in human myotubes. It is unknown whether different types of fatty acids like eicosapentaenoic acid (EPA) or tetradecylthioacetic acid (TTA) influence these proc...
Autores principales: | , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2646050/ https://www.ncbi.nlm.nih.gov/pubmed/19066312 http://dx.doi.org/10.2337/db08-1043 |
_version_ | 1782164813858734080 |
---|---|
author | Wensaas, Andreas J. Rustan, Arild C. Just, Marlene Berge, Rolf K. Drevon, Christian A. Gaster, Michael |
author_facet | Wensaas, Andreas J. Rustan, Arild C. Just, Marlene Berge, Rolf K. Drevon, Christian A. Gaster, Michael |
author_sort | Wensaas, Andreas J. |
collection | PubMed |
description | OBJECTIVE—Increased availability of fatty acids is important for accumulation of intracellular lipids and development of insulin resistance in human myotubes. It is unknown whether different types of fatty acids like eicosapentaenoic acid (EPA) or tetradecylthioacetic acid (TTA) influence these processes. RESEARCH DESIGN AND METHODS—We examined fatty acid and glucose metabolism and gene expression in cultured human skeletal muscle cells from control and type 2 diabetic individuals after 4 days of preincubation with EPA or TTA. RESULTS—Type 2 diabetes myotubes exhibited reduced formation of CO(2) from palmitic acid (PA), whereas release of β-oxidation products was unchanged at baseline but significantly increased with respect to control myotubes after preincubation with TTA and EPA. Preincubation with TTA enhanced both complete (CO(2)) and β-oxidation of palmitic acid, whereas EPA increased only β-oxidation significantly. EPA markedly enhanced triacylglycerol (TAG) accumulation in myotubes, more pronounced in type 2 diabetes cells. TAG accumulation and fatty acid oxidation were inversely correlated only after EPA preincubation, and total level of acyl-CoA was reduced. Glucose oxidation (CO(2) formation) was enhanced and lactate production decreased after chronic exposure to EPA and TTA, whereas glucose uptake and storage were unchanged. EPA and especially TTA increased the expression of genes involved in fatty acid uptake, activation, accumulation, and oxidation. CONCLUSIONS—Our results suggest that 1) mitochondrial dysfunction in diabetic myotubes is caused by disturbances downstream of fatty acid β-oxidation; 2) EPA promoted accumulation of TAG, enhanced β-oxidation, and increased glucose oxidation; and 3) TTA improved complete palmitic acid oxidation in diabetic myotubes, opposed increased lipid accumulation, and increased glucose oxidation. |
format | Text |
id | pubmed-2646050 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2009 |
publisher | American Diabetes Association |
record_format | MEDLINE/PubMed |
spelling | pubmed-26460502010-03-01 Fatty Acid Incubation of Myotubes From Humans With Type 2 Diabetes Leads to Enhanced Release of β-Oxidation Products Because of Impaired Fatty Acid Oxidation: Effects of Tetradecylthioacetic Acid and Eicosapentaenoic Acid Wensaas, Andreas J. Rustan, Arild C. Just, Marlene Berge, Rolf K. Drevon, Christian A. Gaster, Michael Diabetes Metabolism OBJECTIVE—Increased availability of fatty acids is important for accumulation of intracellular lipids and development of insulin resistance in human myotubes. It is unknown whether different types of fatty acids like eicosapentaenoic acid (EPA) or tetradecylthioacetic acid (TTA) influence these processes. RESEARCH DESIGN AND METHODS—We examined fatty acid and glucose metabolism and gene expression in cultured human skeletal muscle cells from control and type 2 diabetic individuals after 4 days of preincubation with EPA or TTA. RESULTS—Type 2 diabetes myotubes exhibited reduced formation of CO(2) from palmitic acid (PA), whereas release of β-oxidation products was unchanged at baseline but significantly increased with respect to control myotubes after preincubation with TTA and EPA. Preincubation with TTA enhanced both complete (CO(2)) and β-oxidation of palmitic acid, whereas EPA increased only β-oxidation significantly. EPA markedly enhanced triacylglycerol (TAG) accumulation in myotubes, more pronounced in type 2 diabetes cells. TAG accumulation and fatty acid oxidation were inversely correlated only after EPA preincubation, and total level of acyl-CoA was reduced. Glucose oxidation (CO(2) formation) was enhanced and lactate production decreased after chronic exposure to EPA and TTA, whereas glucose uptake and storage were unchanged. EPA and especially TTA increased the expression of genes involved in fatty acid uptake, activation, accumulation, and oxidation. CONCLUSIONS—Our results suggest that 1) mitochondrial dysfunction in diabetic myotubes is caused by disturbances downstream of fatty acid β-oxidation; 2) EPA promoted accumulation of TAG, enhanced β-oxidation, and increased glucose oxidation; and 3) TTA improved complete palmitic acid oxidation in diabetic myotubes, opposed increased lipid accumulation, and increased glucose oxidation. American Diabetes Association 2009-03 /pmc/articles/PMC2646050/ /pubmed/19066312 http://dx.doi.org/10.2337/db08-1043 Text en Copyright © 2009, American Diabetes Association Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details. |
spellingShingle | Metabolism Wensaas, Andreas J. Rustan, Arild C. Just, Marlene Berge, Rolf K. Drevon, Christian A. Gaster, Michael Fatty Acid Incubation of Myotubes From Humans With Type 2 Diabetes Leads to Enhanced Release of β-Oxidation Products Because of Impaired Fatty Acid Oxidation: Effects of Tetradecylthioacetic Acid and Eicosapentaenoic Acid |
title | Fatty Acid Incubation of Myotubes From Humans With Type 2 Diabetes Leads to Enhanced Release of β-Oxidation Products Because of Impaired Fatty Acid Oxidation: Effects of Tetradecylthioacetic Acid and Eicosapentaenoic Acid |
title_full | Fatty Acid Incubation of Myotubes From Humans With Type 2 Diabetes Leads to Enhanced Release of β-Oxidation Products Because of Impaired Fatty Acid Oxidation: Effects of Tetradecylthioacetic Acid and Eicosapentaenoic Acid |
title_fullStr | Fatty Acid Incubation of Myotubes From Humans With Type 2 Diabetes Leads to Enhanced Release of β-Oxidation Products Because of Impaired Fatty Acid Oxidation: Effects of Tetradecylthioacetic Acid and Eicosapentaenoic Acid |
title_full_unstemmed | Fatty Acid Incubation of Myotubes From Humans With Type 2 Diabetes Leads to Enhanced Release of β-Oxidation Products Because of Impaired Fatty Acid Oxidation: Effects of Tetradecylthioacetic Acid and Eicosapentaenoic Acid |
title_short | Fatty Acid Incubation of Myotubes From Humans With Type 2 Diabetes Leads to Enhanced Release of β-Oxidation Products Because of Impaired Fatty Acid Oxidation: Effects of Tetradecylthioacetic Acid and Eicosapentaenoic Acid |
title_sort | fatty acid incubation of myotubes from humans with type 2 diabetes leads to enhanced release of β-oxidation products because of impaired fatty acid oxidation: effects of tetradecylthioacetic acid and eicosapentaenoic acid |
topic | Metabolism |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2646050/ https://www.ncbi.nlm.nih.gov/pubmed/19066312 http://dx.doi.org/10.2337/db08-1043 |
work_keys_str_mv | AT wensaasandreasj fattyacidincubationofmyotubesfromhumanswithtype2diabetesleadstoenhancedreleaseofboxidationproductsbecauseofimpairedfattyacidoxidationeffectsoftetradecylthioaceticacidandeicosapentaenoicacid AT rustanarildc fattyacidincubationofmyotubesfromhumanswithtype2diabetesleadstoenhancedreleaseofboxidationproductsbecauseofimpairedfattyacidoxidationeffectsoftetradecylthioaceticacidandeicosapentaenoicacid AT justmarlene fattyacidincubationofmyotubesfromhumanswithtype2diabetesleadstoenhancedreleaseofboxidationproductsbecauseofimpairedfattyacidoxidationeffectsoftetradecylthioaceticacidandeicosapentaenoicacid AT bergerolfk fattyacidincubationofmyotubesfromhumanswithtype2diabetesleadstoenhancedreleaseofboxidationproductsbecauseofimpairedfattyacidoxidationeffectsoftetradecylthioaceticacidandeicosapentaenoicacid AT drevonchristiana fattyacidincubationofmyotubesfromhumanswithtype2diabetesleadstoenhancedreleaseofboxidationproductsbecauseofimpairedfattyacidoxidationeffectsoftetradecylthioaceticacidandeicosapentaenoicacid AT gastermichael fattyacidincubationofmyotubesfromhumanswithtype2diabetesleadstoenhancedreleaseofboxidationproductsbecauseofimpairedfattyacidoxidationeffectsoftetradecylthioaceticacidandeicosapentaenoicacid |